NASDAQ:PDEX - Pro-Dex Stock Price, Price Target & More

$6.80 0.00 (0.00 %)
(As of 04/26/2018 11:42 AM ET)
Previous Close$6.80
Today's Range$6.60 - $6.85
52-Week Range$4.65 - $8.00
Volume5,800 shs
Average Volume7,720 shs
Market Capitalization$29.65 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.32

About Pro-Dex (NASDAQ:PDEX)

Pro-Dex, Inc. (Pro-Dex) designs and produces surgical and dental instruments and motion control products used in the medical, factory automation and scientific research industries. The Company operates through four segments: Pro-Dex, OMS, Fineline and Engineering Services Division (ESD). The Pro-Dex segment provides primarily medical and dental instruments using shared production and assembly machines and workforce. The OMS segment is engaged in providing multi-axis motion control applications. The Fineline segment manufactures plastic injection molds for various industries. The ESD segment provides permanent placement and contract services in the fields of engineering, manufacturing and quality to diverse businesses. In addition to Pro-Dex, the names Micro Motors and Oregon Micro Systems are used for marketing purposes as brand names. It provides engineering consulting services, as well as quality and regulatory consulting services, to a range of industries through EDS.

Receive PDEX News and Ratings via Email

Sign-up to receive the latest news and ratings for PDEX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:PDEX
CUSIPN/A
Phone949-769-3200

Debt

Debt-to-Equity RatioN/A
Current Ratio7.07%
Quick Ratio5.45%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$21.94 million
Price / Sales1.35
Cash Flow$1.3710 per share
Price / Cash4.96
Book Value$3.42 per share
Price / Book1.99

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$5.08 million
Net Margins11.23%
Return on Equity16.04%
Return on Assets13.93%

Miscellaneous

Employees76
Outstanding Shares4,360,000

How to Become a New Pot Stock Millionaire

Pro-Dex (NASDAQ:PDEX) Frequently Asked Questions

What is Pro-Dex's stock symbol?

Pro-Dex trades on the NASDAQ under the ticker symbol "PDEX."

How were Pro-Dex's earnings last quarter?

Pro-Dex, Inc. (NASDAQ:PDEX) announced its quarterly earnings data on Tuesday, February, 10th. The medical instruments supplier reported ($0.05) EPS for the quarter. The medical instruments supplier had revenue of $2.80 million for the quarter, compared to analyst estimates of $2.60 million. Pro-Dex had a return on equity of 16.04% and a net margin of 11.23%. View Pro-Dex's Earnings History.

What price target have analysts set for PDEX?

1 equities research analysts have issued 1-year price targets for Pro-Dex's stock. Their forecasts range from $9.00 to $9.00. On average, they expect Pro-Dex's share price to reach $9.00 in the next year. View Analyst Ratings for Pro-Dex.

Who are some of Pro-Dex's key competitors?

Who are Pro-Dex's key executives?

Pro-Dex's management team includes the folowing people:
  • Nicholas John Swenson, Independent Chairman of the Board (Age 48)
  • Richard L. Van Kirk Jr., President, Chief Executive Officer, Chief Operating Officer, Director (Age 56)
  • Alisha K. Charlton, Chief Financial Officer (Age 47)
  • Raymond E. Cabillot, Independent Director (Age 53)
  • William J. Farrell III, Independent Director (Age 43)
  • David C. Hovda, Independent Director (Age 54)

Has Pro-Dex been receiving favorable news coverage?

Media coverage about PDEX stock has trended positive on Thursday, according to Accern Sentiment. The research group identifies negative and positive press coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Pro-Dex earned a news sentiment score of 0.28 on Accern's scale. They also gave media coverage about the medical instruments supplier an impact score of 47.94 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next several days.

How do I buy shares of Pro-Dex?

Shares of PDEX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Pro-Dex's stock price today?

One share of PDEX stock can currently be purchased for approximately $6.80.

How big of a company is Pro-Dex?

Pro-Dex has a market capitalization of $29.65 million and generates $21.94 million in revenue each year. Pro-Dex employs 76 workers across the globe.

How can I contact Pro-Dex?

Pro-Dex's mailing address is 2361 MCGAW AVENUE, IRVINE CA, 92614. The medical instruments supplier can be reached via phone at 949-769-3200 or via email at [email protected]


MarketBeat Community Rating for Pro-Dex (PDEX)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  50 (Vote Outperform)
Underperform Votes:  60 (Vote Underperform)
Total Votes:  110
MarketBeat's community ratings are surveys of what our community members think about Pro-Dex and other stocks. Vote "Outperform" if you believe PDEX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PDEX will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Pro-Dex (NASDAQ:PDEX) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
1 Wall Street analysts have issued ratings and price targets for Pro-Dex in the last 12 months. Their average twelve-month price target is $9.00, suggesting that the stock has a possible upside of 32.35%. The high price target for PDEX is $9.00 and the low price target for PDEX is $9.00. There are currently 1 buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $9.00$9.00$9.00$9.00
Price Target Upside: 32.35% upside20.00% upside20.00% upside20.00% upside

Pro-Dex (NASDAQ:PDEX) Consensus Price Target History

Price Target History for Pro-Dex (NASDAQ:PDEX)

Pro-Dex (NASDAQ:PDEX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/8/2017Ascendiant Capital MarketsReiterated RatingBuy$8.00 -> $9.00LowView Rating Details
(Data available from 4/26/2016 forward)

Earnings

Pro-Dex (NASDAQ:PDEX) Earnings History and Estimates Chart

Earnings by Quarter for Pro-Dex (NASDAQ:PDEX)

Pro-Dex (NASDAQ PDEX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/11/2017Q3 2017$0.17$6.62 millionViewN/AView Earnings Details
2/9/2017Q2 2017$0.77$4.60 millionViewN/AView Earnings Details
9/15/2016Q4 2016$0.05$5.29 millionViewN/AView Earnings Details
5/12/2016Q3 2016$0.08$5.34 millionViewN/AView Earnings Details
2/11/2016Q2 2016$0.09$5.44 millionViewN/AView Earnings Details
11/10/2015Q1 2016($0.03)$4.10 millionViewN/AView Earnings Details
9/17/2015Q4 2015$0.02$4.07 millionViewN/AView Earnings Details
5/14/2015Q3 2015($0.02)$3.92 millionViewN/AView Earnings Details
2/10/2015Q215($0.05)$2.60 million$2.80 millionViewN/AView Earnings Details
11/13/2014Q115($0.04)$2.55 million$2.60 millionViewN/AView Earnings Details
9/18/2014Q4 14$0.01$3.20 millionViewN/AView Earnings Details
5/12/2014Q3 2014($0.11)$2.40 millionViewN/AView Earnings Details
2/6/2014Q4($0.10)$2.64 millionViewN/AView Earnings Details
11/13/2013Q114$0.06$3.50 million$2.60 millionViewN/AView Earnings Details
9/25/2013Q413($0.20)$3.70 million$2.70 millionViewN/AView Earnings Details
5/13/2013Q3 2013($0.23)$3.06 millionViewN/AView Earnings Details
1/10/2013Q2 2013($0.11)ViewN/AView Earnings Details
10/25/2012Q1 2013($0.02)ViewN/AView Earnings Details
9/4/2012Q4 2012($0.14)ViewN/AView Earnings Details
5/4/2012Q3 2012($0.16)ViewN/AView Earnings Details
2/6/2012Q2 2012($0.09)ViewN/AView Earnings Details
11/9/2011Q1 2012$0.14ViewN/AView Earnings Details
9/14/2011Q4 2011$0.31ViewN/AView Earnings Details
5/10/2011Q3 2011$0.26ViewN/AView Earnings Details
2/10/2011Q2 2011$0.12ViewN/AView Earnings Details
11/9/2010Q1 2011$0.10ViewN/AView Earnings Details
9/28/2010Q4 2010($1.20)ViewN/AView Earnings Details
4/29/2010Q3 2010$0.05ViewN/AView Earnings Details
2/4/2010Q2 2010$0.18ViewN/AView Earnings Details
10/29/2009Q1 2010$0.06ViewN/AView Earnings Details
9/17/2009Q4 2009$0.06ViewN/AView Earnings Details
5/14/2009Q3 2009($0.62)ViewN/AView Earnings Details
2/12/2009Q2 2009$0.02ViewN/AView Earnings Details
11/13/2008Q1 2009($0.04)ViewN/AView Earnings Details
9/18/2008Q4 2008($0.12)ViewN/AView Earnings Details
5/15/2008Q3 2008$0.03ViewN/AView Earnings Details
2/14/2008Q2 2008$0.09ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Pro-Dex (NASDAQ:PDEX) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Pro-Dex (NASDAQ PDEX) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 40.70%
Institutional Ownership Percentage: 6.13%
Insider Trading History for Pro-Dex (NASDAQ:PDEX)

Pro-Dex (NASDAQ PDEX) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/12/2018William James Farrell IIIDirectorBuy2,200$6.75$14,850.00View SEC Filing  
5/18/2017Kirk Richard Lee Van JrCEOSell940$5.75$5,405.0018,760View SEC Filing  
3/23/2016William James Farrell IIIDirectorBuy600$3.42$2,052.001,700View SEC Filing  
3/2/2016Nicholas John SwensonDirectorBuy1,281$3.15$4,035.1575,388View SEC Filing  
3/1/2016Nicholas John SwensonDirectorBuy17,821$3.15$56,136.1575,388View SEC Filing  
1/15/2016Raymond E CabillotDirectorBuy14,913$2.25$33,554.25View SEC Filing  
1/14/2016Nicholas John SwensonDirectorBuy7,353$2.30$16,911.9055,974View SEC Filing  
9/15/2015Nicholas John SwensonDirectorBuy22,537$2.30$51,835.1047,588View SEC Filing  
8/21/2015Nicholas John SwensonDirectorBuy4,020$2.28$9,165.6014,341View SEC Filing  
7/20/2015Raymond E CabillotDirectorBuy1,700$2.30$3,910.00View SEC Filing  
5/28/2015Kirk Richard Lee Van JrCEOBuy5,100$2.32$11,832.00View SEC Filing  
4/30/2014Harold A HurwitzCEOBuy2,203$1.90$4,185.70View SEC Filing  
4/30/2014Nicholas John SwensonDirectorBuy317,231$1.90$602,738.90View SEC Filing  
8/29/2013Raymond E CabillotDirectorBuy10,500$1.90$19,950.00View SEC Filing  
8/19/2013Nicholas John SwensonDirectorBuy5,702$1.90$10,833.80View SEC Filing  
7/12/2013Nicholas John SwensonDirectorBuy5,545$1.90$10,535.50View SEC Filing  
7/3/2013Nicholas John SwensonDirectorBuy5,000$1.90$9,500.00View SEC Filing  
6/25/2013Nicholas John SwensonDirectorBuy5,373$1.90$10,208.70View SEC Filing  
6/19/2013Raymond E CabillotDirectorBuy1,279$1.90$2,430.10View SEC Filing  
6/11/2013Nicholas John SwensonDirectorBuy4,950$1.90$9,405.00View SEC Filing  
6/3/2013Nicholas John SwensonDirectorBuy12,303$1.90$23,375.70View SEC Filing  
5/24/2013Raymond E CabillotDirectorBuy8,312$1.90$15,792.80View SEC Filing  
5/21/2013Nicholas John SwensonDirectorBuy3,510$1.90$6,669.00View SEC Filing  
5/14/2013Raymond E CabillotDirectorBuy25,119$1.99$49,986.81View SEC Filing  
5/7/2013Nicholas John SwensonDirectorBuy28,206$2.00$56,412.00View SEC Filing  
4/30/2013Raymond E CabillotDirectorBuy5,176$2.00$10,352.00View SEC Filing  
4/17/2013Nicholas John SwensonMajor ShareholderBuy12,859$2.00$25,718.00View SEC Filing  
4/16/2013Raymond E CabillotDirectorBuy12,758$2.00$25,516.00View SEC Filing  
4/9/2013Nicholas John SwensonMajor ShareholderBuy2,293$2.00$4,586.00View SEC Filing  
4/9/2013Raymond E CabillotDirectorBuy2,294$2.00$4,588.00View SEC Filing  
3/8/2013Raymond E CabillotDirectorBuy25,560$2.00$51,120.00View SEC Filing  
11/19/2012Nicholas John SwensonMajor ShareholderBuy9,884$1.97$19,471.48View SEC Filing  
10/25/2012Nicholas John SwensonMajor ShareholderBuy1,485$1.87$2,776.95View SEC Filing  
10/18/2012Nicholas John SwensonMajor ShareholderBuy29,442$1.90$55,939.80View SEC Filing  
10/5/2012Nicholas John SwensonMajor ShareholderBuy6,743$1.89$12,744.27View SEC Filing  
10/1/2012Nicholas John SwensonMajor ShareholderBuy2,384$1.80$4,291.20View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Pro-Dex (NASDAQ PDEX) News Headlines

Source:
DateHeadline
Pro-Dex Inc (PDEX) Director Buys $14,850.00 in StockPro-Dex Inc (PDEX) Director Buys $14,850.00 in Stock
www.americanbankingnews.com - February 13 at 6:46 PM
Rick Van Kirk, CEO of Pro-Dex, Inc. Returns to “Stock Day” with Everett JollyRick Van Kirk, CEO of Pro-Dex, Inc. Returns to “Stock Day” with Everett Jolly
finance.yahoo.com - February 12 at 9:03 AM
Pro-Dex, Inc. Announces Fiscal 2018 Second Quarter and Six-Month ResultsPro-Dex, Inc. Announces Fiscal 2018 Second Quarter and Six-Month Results
finance.yahoo.com - February 8 at 4:26 PM
Pro-Dex (PDEX) Set to Announce Earnings on WednesdayPro-Dex (PDEX) Set to Announce Earnings on Wednesday
www.americanbankingnews.com - January 31 at 3:04 AM
Uptick Newswire “Stock Day” Interviews CEO of Pro-Dex on its 2017 Accomplishments in the Medical IndustryUptick Newswire “Stock Day” Interviews CEO of Pro-Dex on its 2017 Accomplishments in the Medical Industry
finance.yahoo.com - December 21 at 10:17 AM
ETFs with exposure to Pro-Dex, Inc. : December 19, 2017ETFs with exposure to Pro-Dex, Inc. : December 19, 2017
finance.yahoo.com - December 19 at 4:35 PM
Pro-Dex, Inc. :PDEX-US: Earnings Analysis: Q1, 2018 By the Numbers : December 18, 2017Pro-Dex, Inc. :PDEX-US: Earnings Analysis: Q1, 2018 By the Numbers : December 18, 2017
finance.yahoo.com - December 18 at 4:36 PM
Pro-Dex, Inc. Announces Top Workplace Recognition, Best Scientific Medical Product Award and Placement as a Fastest-Growing Orange County CompanyPro-Dex, Inc. Announces Top Workplace Recognition, Best Scientific Medical Product Award and Placement as a Fastest-Growing Orange County Company
finance.yahoo.com - December 12 at 4:56 PM
Pro-Dex, Inc. Announces Fiscal 2018 First Quarter ResultsPro-Dex, Inc. Announces Fiscal 2018 First Quarter Results
finance.yahoo.com - November 12 at 11:31 AM
ETFs with exposure to Pro-Dex, Inc. : November 6, 2017ETFs with exposure to Pro-Dex, Inc. : November 6, 2017
finance.yahoo.com - November 7 at 8:34 AM
ETFs with exposure to Pro-Dex, Inc. : October 26, 2017ETFs with exposure to Pro-Dex, Inc. : October 26, 2017
finance.yahoo.com - October 27 at 9:29 AM
Should You Buy Pro-Dex Inc (PDEX) At $7.2?Should You Buy Pro-Dex Inc (PDEX) At $7.2?
finance.yahoo.com - October 3 at 10:30 AM
ETFs with exposure to Pro-Dex, Inc. : October 2, 2017ETFs with exposure to Pro-Dex, Inc. : October 2, 2017
finance.yahoo.com - October 3 at 10:30 AM
Pro-Dex, Inc. :PDEX-US: Earnings Analysis: Q4, 2017 By the Numbers : September 25, 2017Pro-Dex, Inc. :PDEX-US: Earnings Analysis: Q4, 2017 By the Numbers : September 25, 2017
finance.yahoo.com - September 25 at 10:52 AM
ETFs with exposure to Pro-Dex, Inc. : September 19, 2017ETFs with exposure to Pro-Dex, Inc. : September 19, 2017
finance.yahoo.com - September 20 at 7:35 AM
ETFs with exposure to Pro-Dex, Inc. : September 19, 2017ETFs with exposure to Pro-Dex, Inc. : September 19, 2017
finance.yahoo.com - September 20 at 7:35 AM
Pro-Dex, Inc. :PDEX-US: Earnings Analysis: 2017 By the Numbers : September 18, 2017Pro-Dex, Inc. :PDEX-US: Earnings Analysis: 2017 By the Numbers : September 18, 2017
finance.yahoo.com - September 19 at 6:27 AM
Pro-Dexs (PDEX) "Buy" Rating Reiterated at Ascendiant Capital MarketsPro-Dex's (PDEX) "Buy" Rating Reiterated at Ascendiant Capital Markets
www.americanbankingnews.com - September 9 at 11:58 AM
Pro-Dex, Inc. Announces Fiscal 2017 Fourth Quarter and Full-Year ResultsPro-Dex, Inc. Announces Fiscal 2017 Fourth Quarter and Full-Year Results
finance.yahoo.com - September 5 at 5:10 PM
Pro-Dex CEO Overviews with Uptick Network on Company Progression in its Technologies and Customer RelationsPro-Dex CEO Overviews with Uptick Network on Company Progression in its Technologies and Customer Relations
finance.yahoo.com - August 18 at 7:01 AM
PRO DEX INC Files SEC form 8-K, Change in Directors or Principal OfficersPRO DEX INC Files SEC form 8-K, Change in Directors or Principal Officers
biz.yahoo.com - September 14 at 6:49 PM
PRO DEX INC Files SEC form 8-K, Other EventsPRO DEX INC Files SEC form 8-K, Other Events
biz.yahoo.com - April 19 at 5:05 PM
PRO DEX INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and ExhibitsPRO DEX INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
biz.yahoo.com - January 8 at 12:58 PM
PRO DEX INC Files SEC form 8-K, Submission of Matters to a Vote of Security HoldersPRO DEX INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
biz.yahoo.com - December 7 at 3:06 PM
PRO DEX INC Files SEC form 8-K, Results of Operations and Financial ConditionPRO DEX INC Files SEC form 8-K, Results of Operations and Financial Condition
biz.yahoo.com - November 10 at 4:06 PM
PRO DEX INC Files SEC form 10-Q, Quarterly ReportPRO DEX INC Files SEC form 10-Q, Quarterly Report
biz.yahoo.com - November 10 at 4:04 PM
PRO DEX INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial ObligationPRO DEX INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation
biz.yahoo.com - September 14 at 4:02 PM
PRO DEX INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition or DispositionPRO DEX INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition
biz.yahoo.com - May 13 at 4:07 PM

SEC Filings

Pro-Dex (NASDAQ:PDEX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Pro-Dex (NASDAQ:PDEX) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Pro-Dex (NASDAQ PDEX) Stock Chart for Thursday, April, 26, 2018

Loading chart…

This page was last updated on 4/26/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.